Cell Source, Inc.
CLCS- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001569340
No open-market purchases or sales by Cell Source, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cell Source, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cell Source, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Soave Darlene | Director, 10% Owner | 174,434 | Aug 11, 2021 | 0 |
| Brown Dennis M | Director | 114,927 | Jul 7, 2021 | 0 |
| Zolty David | Director | 1,127,504Indirect | Jul 7, 2021 | 0 |
| Friedman Benzion Abraham | Director, 10% Owner | 4,408,184Indirect | Jul 7, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.